Yale New Haven Hospital - Investigational Drug Services — New Haven, Connecticut

Yale New Haven Hospital - Investigational Drug Services is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Yale New Haven Hospital - Investigational Drug Services has participated in 2 clinical trials.

Therapeutic areas: Staphylococcal Vaccine, Diabetes Mellitus, Type 1.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale New Haven Hospital - Investigational Drug Services?

Yale New Haven Hospital - Investigational Drug Services has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale New Haven Hospital - Investigational Drug Services conducted?

Yale New Haven Hospital - Investigational Drug Services has 2 clinical trials on record. Their work covers Staphylococcal Vaccine, Diabetes Mellitus, Type 1.

Is Yale New Haven Hospital - Investigational Drug Services accredited by Crixeo Health?

Yale New Haven Hospital - Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale New Haven Hospital - Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.